Effect of Dexamethasone Adjuvant in Combined Supraclavicular Block and Suprascapular Block Versus Interscalene Block in Patients Undergoing Shoulder Arthroscopy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Shoulder arthroscopy blocks.
- Who it may be relevant to
- Registry conditions: Shoulder Arthroscopy Blocks, Dexamethasone. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
In this study the investigators aim to compare the effect of the suprascapular- supraclavicular nerve block in association with dexamethasone to that of the interscalene brachial plexus block on analgesic effect during arthroscopic shoulder surgery, as postoperative pain scores ,postoperative consumption of analgesic rescue medications and diaphragmatic excursion assessment.
Interventions
- Procedure Shoulder arthroscopy blocks
Effect of dexamethasone adjuvant in combined supraclavicular block and suprascapular block versus Interscalene block in patients undergoing shoulder arthroscopy.
Primary outcome measures
- Postoperative analgesia by visual analog scale (VAS). [Time frame: 48 hours]
Secondary outcome measures (1)
- Diaphragmatic excursion [Time frame: 1hour postoperatively]
Eligibility criteria
Inclusion criteria
- ASA status 1,2.
- Age 18 years or older
- Elective shoulder arthroscopic surgery under general anesthesia and nerve block performed preoperatively.
Exclusion criteria
- • Patient refusal
- Serious cardiac arrhythmias (including atrial fibrillation) or unstable coronary artery disease.
- Use of drugs that act on the autonomic nervous system (including β- blockers).
- Coagulation disorders..
- Anatomical disorders and/or neuropathic disease.
- BMI above 40.
- History of substance abuse.
- Chronic use of psychotropic and/or opioid.
- History of psychiatric diseases needing treatment.
- Allergy to any drug in the study protocol.
- Failure of nerve block performed in the preoperative block room when tested prior to entering the operating room (i.e. lack of loss of sensation to ice at the shoulder incision level).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Assiut University — Asyut
Identifiers
NCT: NCT06262893 · Shoulder nerve blocks